Armistice Capital »

Calumet shares owned by Armistice Capital

Quarter-by-quarter ownership of Calumet (CLMT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Calumet

Tip: Access up to 7 years of quarterly data

All positions including Calumet held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calumet by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $263k 7.3k 35.90

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Calumet

Two Seas Capital
BlackRock
Vanguard Group
Wasserstein Debt Opportunities Management
Vanguard Capital Management
Adams Asset Advisors
Goldman Sachs Group
State Street Corporation
Susquehanna International
Geode Capital Management
Citadel Advisors
Graham Capital Management
Bank of America Corporation
Morgan Stanley
Vanguard Portfolio Management

View all funds holding Calumet